Mild Versus Potent Corticosteroids as Treatment for Phimosis in Children
NCT ID: NCT00933023
Last Updated: 2015-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2009-08-31
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Circumcision Versus Preputioplasty for BXO in Children
NCT02854995
The Role of Local Long Acting Corticosteroid Injection in Hypospadias Surgery.
NCT04196400
Orchidopexy Randomized Clinical Assessment
NCT02235623
Infant Male Circumcision in Gaborone, Botswana, and Surrounding Areas: Feasibility, Safety and Acceptability
NCT00971958
Local Oestrogen Versus Placebo as Preoperative Treatment in Patients With Severe Hypospadias: Effects on Post-operative Complications
NCT01370798
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mild steroid
1%hydrocortisone for 8 weeks
hydrocortisone
1%hydrocortisone topical once daily for 8 weeks
Potent Steroid
Betamethasone
Betamethasone 0.1% topical once daily for 8weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hydrocortisone
1%hydrocortisone topical once daily for 8 weeks
Betamethasone
Betamethasone 0.1% topical once daily for 8weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2 Years
16 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chelsea and Westminster NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anindya Niyogi
Clinical Research Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anindya Niyogi, MBBS, MRCSEd
Role: PRINCIPAL_INVESTIGATOR
Research Fellow in Paediatric Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chelsea and Westminster Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TopSteP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.